Charleston, SC -- (SBWIRE) -- 12/19/2013 -- Hot Shot Stock Alerts is a market and commodities news and marketing web service, providing investing news, business news, headline news, news alerts, personal finance, stock market, and press releases. Hot Shot Stock Alerts carries you the most fascinating reviews and research reports regarding following stocks: Galena Biopharma Inc (NASDAQ:GALE), Arrowhead Research Corp (NASDAQ:ARWR), BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX), Idera Pharmaceuticals Inc (NASDAQ:IDRA)
Galena Biopharma Inc (NASDAQ:GALE) closed latest trading day at $3.94, down -1.50%, on volume of over 2.82 million shares. The stock fell -11.06% in the last 5 days. Its average trading volume is 6.26 million shares. In the time frame of the last one month, the share-price has surged almost +29.61%. Its market capitalization was $414.63 million.
Galena Biopharma, Inc., a biopharmaceutical company, focuses on developing oncology treatments to address major unmet medical needs to advance cancer care. It is developing a pipeline of immunotherapy product candidates for the treatment of various cancers based on the E75 peptide.
Has GALE Found The Bottom and Ready To Move Up? Find Out Here
With the latest rise of +4.46%, Arrowhead Research Corp (NASDAQ:ARWR) now has YTD performance +327.1% which for the week is positive at +19.17%. The total number of shares traded on the latest trading day was about 2.80M shares, and changed hands at price range of $8.60 to $9.49 apiece. The company ended previous trading at $9.14.
Arrowhead Research Corporation operates as a clinical stage therapeutics company. It has development programs in oncology, obesity, and chronic hepatitis B virus (HBV) infection.
What was the Moving Force behind ARWR On Bullish Run? Read This Research Report
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) reported the price of the stock moved up +8.33% and finished the day at $7.02 on above average volume. The total number of shares traded on the latest trading day was about 2.48M shares, and changed hands at price range of $6.60 to $7.15 apiece. The shares rushed about +394.37% since the start of year and has a +4.15% gain in last three months. Narrowing down the performance period, the stock rose +29.52% for the month and a +22.51% gain over the week.
BioCryst Pharmaceuticals, Inc., a biotechnology company, designs, optimizes, and develops novel drugs that block key enzymes involved in the pathogenesis of diseases.
For How Long BCRX will Fight for Profitability? Read This Trend Analysis report
Idera Pharmaceuticals Inc (NASDAQ:IDRA) ended previous trading at $3.44, losing -1.71%. The total number of shares traded on the latest trading day was about 2.47M shares. In the last 5 days it showed a recovery of +38.15% and on its one month graph, shares are +75.51% up. The stock has a 52-week high price of $3.63 and its 52-week low was recorded at $0.19.
Idera Pharmaceuticals, Inc., a clinical stage biotechnology company, engages in the discovery and development of novel synthetic DNA- and RNA- based drug candidates.
Why Should Investors Buy IDRA After the Recent Fall? Just Go Here and Find Out
The disclaimer is to be read and fully understood before using our site, or joining our newsletter email list.
Never invest into a stock discussed on this web site or the HotShotStockAlerts.com newsletter unless you can afford to lose your entire investment.
Please consult with a certified financial advisor before making any investment decisions.
HotShotStockAlerts.com is owned and operated by FlipVentures LLC. We are engaged in the business of advertising and promoting companies for monetary compensation. All content in our releases is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities.
Read full Disclaimer at: http://hotshotstockalerts.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)